Hypertophic cardiomyopathy in infant diabetic mother and glycated albumin in their mothers
Keywords:
Glycated Albumin, Diabetic, Pregnant, Hypertrophic Cardiomyopathy, Gestational diabetesAbstract
Background: Hypertrophic cardiomyopathy represents a co-morbidity in infants. It is characterized by thickening of one or both of the ventricular walls including the interventricular septum in addition to systolic and diastolic dysfunction.Gestational diabetes mellitus (GDM) with poorly controlled glycemia is associated with poor pregnancy outcomes. However, adequate markers for glycemic control in GDM have not been fully evaluated. Hypertrophic cardiomyopathy represents a co-morbidity in infants. It is characterized by thickening of one or both of the ventricular walls including the interventricular septum in addition to systolic and diastolic dysfunction. Summary: In summary, we demonstrated the clinical usefulness of GA and GA/HbA1c in monitoring GDM in late pregnancy and predicting infant complications of GDM. Our data suggested that the use of GA and GA/HbA1c in combination with conventional glycemic control indices might be useful for good glycemic control during pregnancy, although our results need validation in larger, better-designed studies.
Downloads
References
A Moustafa G, Kolokythas A, Charitakis K, V Avgerinos D. (2016). Diagnostic cardiac catheterization in the pediatric population. Current Cardiology Reviews, 12(2), 155–162.
Association A. D. (2018). American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2018. Diabetes Care, 41(Supplement 1), S73 LP-S85.
Blumer, I., Hadar, E., Hadden, D. R., Jovanovic, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013). Diabetes and Pregnancy : An Endocrine Society Clinical Practice Guideline. 98(November), 4227–4249. https://doi.org/10.1210/jc.2013-2465
Cheng YW, Caughey AB. (2008). Gestational diabetes: Diagnosis and management. Journal of Perinatology, 28(10), 657–664. https://doi.org/10.1038/jp.2008.62
Codazzi AC, Ippolito R, Novara C, Tondina E, Cerbo RM, Tzialla C.(2021). Hypertrophic cardiomyopathy in infant newborns of diabetic mother: a heterogeneous condition, the importance of anamnesis, physical examination and follow-up. Ital J Pediatr,47(1):1–6.
Colan S. D. (2010). Hypertrophic cardiomyopathy in childhood. Heart Failure Clinics, 6(4), 433–iii. https://doi.org/10.1016/j.hfc.2010.05.004
Dunn K. E, Caleshu, C, Cirino, A. L, Ho, C. Y, Ashley, E. A. (2013). A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management. Circulation: Cardiovascular Genetics, 6(1), 118–131.
Fetita L. (2014). REVIEW : Consequences of Fetal Exposure to Maternal. 91(June), 3718–3724. https://doi.org/10.1210/jc.2006-0624
Furusyo, N., & Hayashi, J. (2013). Glycated albumin and diabetes mellitus. In Biochimica et Biophysica Acta - General Subjects (Vol. 1830, Issue 12, pp. 5509–5514). https://doi.org/10.1016/j.bbagen.2013.05.010
Hashimoto K, Koga M. (2015). Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus. World Journal of Diabetes, 6(8), 1045–1056. https://doi.org/10.4239/wjd.v6.i8.1045
Hiramatsu Y, Shimizu I, Omori Y, Nakabayashi M. (2012). Determination of reference intervals of glycated albumin and hemoglobin A1c in healthy pregnant Japanese women and analysis of their time courses and influencing factors during pregnancy. Endocrine Journal, 59(2), 145–151. https://doi.org/10.1507/endocrj.k10e-410
Holt H. (2015). NICE ’ s latest guidelines on diabetes in pregnancy : getting the balance right. 32(3), 87–89.
Howey J. E, Bennet W. M, Browning M. C, Jung R. T, Fraser C. G. (1989). Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: use of data on biological variation. Diabetic Medicine : A Journal of the British Diabetic Association, 6(9), 793–796. https://doi.org/10.1111/j.1464-5491.1989.tb01281.x
Huang, T, Kelly, A, Becker, S. A, Cohen, M. S, Stanley, C. A. (2013). Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism. Archives of Disease in Childhood. Fetal and Neonatal Edition, 98(4), F351-4. https://doi.org/10.1136/archdischild-2012-302546
Jain P, Patel PA, Fabbro II M.(2018) Hypertrophic cardiomyopathy and left ventricular outflow tract obstruction: expecting the unexpected. J Cardiothorac Vasc Anesth, 32(1):467–77.
Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2019). Epidemiology of Type 2 Diabetes–Global Burden of Disease and Forecasted Trends. Journal of Epidemiology and Global Health, 10(1), 107–111.
Kjos, S. L, Xiang, A, Buchanan, T. A. (1993). Long-term diabetogenic effect of single pregnancy in previous gestational diabetes mellitus. 227–230.
Koga M, Saito H, Mukai M, Matsumoto S, Kasayama S. (2010). Influence of iron metabolism indices on glycated haemoglobin but not glycated albumin levels in premenopausal women. Acta Diabetologica, 47 Suppl 1, 65–69. https://doi.org/10.1007/s00592-009-0123-6
Koga M. (2014). Glycated albumin; clinical usefulness. Clinica Chimica Acta, 433, 96–104.
Kohzuma, T., Yamamoto, T., Uematsu, Y., Shihabi, Z. K., & Freedman, B. I. (2011). Basic performance of an enzymatic method for glycated albumin and reference range determination. Journal of Diabetes Science and Technology, 5(6), 1455–1462. https://doi.org/10.1177/193229681100500619
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al.(2015). Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Hear Journal-Cardiovascular Imaging, 16(3):233–71.
Langer O, Berkus M, Brustman L, Anyaegbunam A, Mazze R. (1991). Rationale for insulin management in gestational diabetes mellitus. Diabetes, 40 Suppl 2, 186–190. https://doi.org/10.2337/diab.40.2.s186
Lebastchi, J., & Herold, K. C. (2012). Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes. Cold Spring Harbor Perspectives in Medicine, 2(6), a007708–a007708. https://doi.org/10.1101/cshperspect.a007708
Lipshultz, S. E, Cochran, T. R, Briston, D. A, Brown, S. R, Sambatakos, P. J, Miller, T. L, et al. (2013). Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies. Future Cardiology, 9(6), 817–848.
Lowe A. M, Orav E. J, Ph D, Cox G. F, Ph D, Lurie P. R, et al. (2003). The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States. 1647–1655.
Mahardika, I. M. R., Suyasa, I. G. P. D., Kamaryati, N. P., & Wulandari, S. K. (2021). Health literacy is strongest determinant on self-monitoring blood glucose (SMBG) type 2 DM patients during COVID-19 pandemic at public health centre in Tabanan Regency. International Journal of Health & Medical Sciences, 4(3), 288-297. https://doi.org/10.31295/ijhms.v4n3.1752
Manuscript, A. (2013). NIH Public Access. 1–10. https://doi.org/10.1136/archdischild-2012-302546.Hypertrophic
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A. J., Seidman, C. E., & Young, J. B. (2006). Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functi. Circulation, 113(14), 1807–1816. https://doi.org/10.1161/CIRCULATIONAHA.106.174287
Mendes N, Tavares Ribeiro R, Serrano F.(2018). Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus. J Obstet Gynaecol (Lahore), 38(6):762–9.
Mitanchez D. (2010). Foetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes Metabolism, 36(6), 617–627. https://doi.org/10.1016/j.diabet.2010.11.013
Monda E, Rubino M, Lioncino M, Di Fraia F, Pacileo R, Verrillo F, et al.(2021). Hypertrophic cardiomyopathy in children: pathophysiology, diagnosis, and treatment of non-sarcomeric causes. Front Pediatr, 9:632293.
Montagna M. P, Laghi F, Cremona G, Zuppi C, Barbaresi G, Castellana M. L. (1991). Influence of serum proteins on fructosamine concentration in multiple myeloma. Clinica Chimica Acta; International Journal of Clinical Chemistry, 204(1–3), 123–130. https://doi.org/10.1016/0009-8981(91)90223-y
Muthiah R.(2016). Apical Left Ventricular Hypertrophic Cardiomyopathy: A Case Report. Case Reports Clin Med, 5(09):308.
Noites, I, Soares, P, Miranda, J. O, Guimarães, H. (2020). Neonatal cardiomyopathy: a 20-year overview of a reference centre. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), 9(1), e090129.
Pahl, E, Sleeper, L. A, Canter, C. E, Hsu, D. T, Lu, M, Webber, S. A, et al. (2012). Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. Journal of the American College of Cardiology, 59(6), 607–615.
Rowin, E. J., & Maron, M. S. (2016). The role of cardiac MRI in the diagnosis and risk stratification of hypertrophic cardiomyopathy. Arrhythmia & Electrophysiology Review, 5(3), 197.
Russell, N. E, Foley, M, Kinsley, B. T, Firth, R. G, Coffey, M, McAuliffe, F. M. (2008). Effect of pregestational diabetes mellitus on fetal cardiac function and structure. American Journal of Obstetrics and Gynecology, 199(3), 1–7. https://doi.org/10.1016/j.ajog.2008.07.016
Shostrom, D. C. V, Sun, Y, Oleson, J. J, Ferguson, T. S. (2017). History of Gestational Diabetes Mellitus in Relation to Cardiovascular Disease and Cardiovascular Risk Factors in US Women. 8(June), 1–6. https://doi.org/10.3389/fendo.2017.00144
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. The Lancet, 365, 1333–1346.
Sugawara D, Maruyama A, Imanishi T, Sugiyama Y, Ichihashi K. (2016). Complications in Infants of Diabetic Mothers Related to Glycated Albumin and Hemoglobin Levels During Pregnancy. Pediatrics and Neonatology, 57(6), 496–500. https://doi.org/10.1016/j.pedneo.2016.02.003
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Tahara Y, Shima K. (1995). Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care, 18(4), 440–447. https://doi.org/10.2337/diacare.18.4.440
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. (1993). New England Journal of Medicine, 329(14), 977–986. https://doi.org/10.1056/nejm199309303291401
Tissot C, Singh Y, Sekarski N.(2018). Echocardiographic evaluation of ventricular function—for the neonatologist and pediatric intensivist. Front Pediatr, 6:79.
Tsyvian P, Malkin K, Artemieva O, Wladimiroff J. W. (1998). Assessment of left ventricular filling in normally grown fetuses , growth-restricted fetuses and fetuses of diabetic mothers. 33–38.
Vohr, B. R, Boney, C. M. (2008). Gestational diabetes : The forerunner for the development of maternal and childhood obesity and metabolic syndrome ? 21(March), 149–157. https://doi.org/10.1080/14767050801929430
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011). IDF Diabetes Atlas : Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice, 94(3), 311–321. https://doi.org/10.1016/j.diabres.2011.10.029
Williams A, Modder J. (2010). Management of pregnancy complicated by diabetes - Maternal glycaemic control during pregnancy and neonatal management. Early Human Development, 86(5), 269–273. https://doi.org/10.1016/j.earlhumdev.2010.05.001
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
